Aviv Scientific Overview
Aviv Scientific specializes in the treatment of age-related cognitive and functional decline, with a focus on novel applications of hyperbaric medicine to maximize human performance. The company aims to improve the aging process by increasing cognitive and physical performance in healthy aging adults. Based on an exclusive global partnership with the worlds largest hyperbaric medicine and research facility, the Sagol Center at Shamir Medical Center in Israel, Aviv Scientific is rolling out a global network of medical clinics focused on the enhancement of cognitive and physical performance with hyperbaric medicine and related technologies at its core. The Aviv Medical Program combines the unique protocols of hyperbaric oxygen therapy (HBOT) with a proprietary personalized program of cognitive and physical training. More than 1,000 people worldwide have already been treated in accordance with Avivs progressive 12-week program, currently offered at Aviv clinics in Florida and Dubai. Aviv Scientific has successfully combined personalized medicine, advanced technologies, big data, and analytics with its specialized operational skills to build a worldwide network of medical clinics.
Cumulative Funding Raised Over Time ($)
$22.0MJun 2021
$62.0MSep 2021
Latest News
growth-positive
Aviv Clinics Highlights New Hyperbaric Oxygen Therapy Study Bringing Hope to Fibromyalgia Patients
A new study conducted by the Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center and Tel Aviv University has found that hyperbaric oxygen therapy (HBOT) is more effective than pharmaceutical treatment for fibromyalgia patients with a history of traumatic brain injury (TBI). The study revealed that HBOT significantly improved pain symptoms, quality of life, and brain activity in relevant brain regions. It also shed light on the biology responsible for fibromyalgia, linking it to mechanical injury to the brain. Aviv Clinics, a leading brain research and medical clinic, offers an advanced treatment program that includes HBOT to repair and regenerate damaged brain tissue. The studys findings provide hope for fibromyalgia patients and open up new therapeutic possibilities.
Customers
growth-positive
Aviv Clinics and Sagol Center for Hyperbaric Medicine and Research Present Webinar on Research Findings from the First Long COVID Clinical Trial to Show Symptom Relief
Aviv Clinics and Sagol Center for Hyperbaric Medicine and Research are hosting a live webinar to discuss a recently published research study on an effective treatment for long COVID symptoms. The webinar is in response to the Department of Health & Human Services National Research and Action Plan on Long COVID. The clinical trial conducted by the Sagol Center and Tel Aviv University showed significant improvement in cognitive function for patients treated with hyperbaric oxygen therapy. The webinar is open to the public and aims to provide hope and transparency regarding long COVID research and treatments.
Customers
growth-positive
Aviv Clinics Highlights New Study Showing Hyperbaric Oxygen Therapy Can Improve Symptoms and Brain Structure of Veterans Suffering from Treatment-Resistant PTSD
Aviv Clinics, a leader in the research and treatment of age-related cognitive and functional decline, has shared the results of a study showing that hyperbaric oxygen therapy (HBOT) can improve symptoms and brain structure in veterans with treatment-resistant PTSD. The study was conducted by the Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center and Tel Aviv University. The clinical trial included 35 veterans who failed all current available treatments. The study revealed that HBOT treatment improved all PTSD symptoms, including intrusive symptoms, avoidance, cognition and mood changes, and depression. The findings suggest that HBOT-induced neuroplasticity could be a new therapeutic strategy for chronic PTSD. Aviv Clinics offers an advanced treatment program that includes HBOT, cognitive training, and personalized plans to improve patients quality of life.
Customers
growth-positive
Aging process data co Aviv Scientific raises $40m
Aviv Scientific, an Israeli cognitive and functional decline treatment company, has closed a $40 million oversubscribed Series B financing round led by Danel and Deep Insight Fund. The funding will be used to expand Avivs clinics globally, develop the Aviv Aging Database, and accelerate medical research. Aviv is focused on developing comprehensive OMICS data to understand the aging process in healthy adults and extend health-span. The company collects neuro-cognitive, physiologic, biomarkers, and genetic evaluations using comprehensive assessments and continuous monitoring. Avivs program combines Hyperbaric Oxygen Therapy with cognitive and physical training. The funding round reflects the companys clinical outcomes, team, partnerships, and technology. Aviv aims to be a leader in the healthy aging movement.
InvestmentExpand
growth-positive
https://www.jpost.com/must/must-innovate-664870
Aviv Scientific, an Israeli company specializing in research and treatment in the aging process, is establishing a medical center in Dubai. This collaboration symbolizes a new era of cooperation between the United Arab Emirates and Israel in advanced medicine. The center will focus on treating and optimizing brain and body performance and will be the second Aviv Clinic in the world. The opening of the center is one of the first examples of the implementation of the Abraham Accords and the normalization of relations between the countries. The center is expected to employ 100 staff members and will have a multidisciplinary team of medical professionals. The Aviv Clinics program, developed by Prof. Shai Efrati and the Aviv team, has been proven to improve cognitive abilities and reverse biological processes associated with aging.
Partners
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $62M |
| Last funding | $40M |
| Stage | B |
| Rounds | 2 |
| Investors | 3 |
Team Members
12
Employees: 11-50
Web & Social Links
| Website | aviv-clinics.com/ |
| Careers | Careers page |
| App Store | App Store |
Locations
Metsada St 7, Bnei Brak, Israel
Jumeirah Lake Towers - Dubai - United Arab Emirates
The Villages, Florida, USA
Photos & Videos
1 item(s)
Aviv Scientific Business
Business models
B2B
Product stage
Released
Employees
11-50
Sector
Health Tech & Life SciencesDigital HealthcareDigital TherapeuticsTarget Customer
Healthcare & Life SciencesHealthcareProvidersPatientsConsumersDemographics & FamilySeniorsCore Technology
Artificial IntelligencePlatforms & InterfacesMobileSemiconductors & ElectronicsWearablesTags (17)
digital-healthcaremedical-datanutritionclinicsmobile-applicationsdata-scienceactionable-insightstherapeuticsdigital-therapeuticshome-carepreventionpersonalizationbig-data-analyticsseniorswearableartificial-intelligenceaging-populationGeographic Markets
AsiaUnited Arab EmiratesUnited StatesEuropeAviv Scientific Financials
$62M
Total funding
Undisclosed
Capital raised
$40M
Last funding
B
Funding stage
2
Total rounds
3
Investors
Cumulative Funding Raised Over Time ($)
$22.0MJun 2021
$62.0MSep 2021
Private Equity Funding
B Round
Sep 2021
$40M
Deep Insight (Lead)
,
Danel Group
Undisclosed Round
Jun 2021
$22M
Danel Group (Lead)
Aviv Scientific Lifecycle
Cumulative Funding Raised Over Time
$22.0MJun 2021
$62.0MSep 2021
All Events
B Round
Sep 2021
$40M
Deep Insight (Lead)
,
Danel Group
Undisclosed Round
Jun 2021
$22M
Danel Group (Lead)
Aviv Scientific News
8 articles
growth-positive
Aviv Clinics Highlights New Hyperbaric Oxygen Therapy Study Bringing Hope to Fibromyalgia Patients
A new study conducted by the Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center and Tel Aviv University has found that hyperbaric oxygen therapy (HBOT) is more effective than pharmaceutical treatment for fibromyalgia patients with a history of traumatic brain injury (TBI). The study revealed that HBOT significantly improved pain symptoms, quality of life, and brain activity in relevant brain regions. It also shed light on the biology responsible for fibromyalgia, linking it to mechanical injury to the brain. Aviv Clinics, a leading brain research and medical clinic, offers an advanced treatment program that includes HBOT to repair and regenerate damaged brain tissue. The studys findings provide hope for fibromyalgia patients and open up new therapeutic possibilities.
Customers
growth-positive
Aviv Clinics and Sagol Center for Hyperbaric Medicine and Research Present Webinar on Research Findings from the First Long COVID Clinical Trial to Show Symptom Relief
Aviv Clinics and Sagol Center for Hyperbaric Medicine and Research are hosting a live webinar to discuss a recently published research study on an effective treatment for long COVID symptoms. The webinar is in response to the Department of Health & Human Services National Research and Action Plan on Long COVID. The clinical trial conducted by the Sagol Center and Tel Aviv University showed significant improvement in cognitive function for patients treated with hyperbaric oxygen therapy. The webinar is open to the public and aims to provide hope and transparency regarding long COVID research and treatments.
Customers
growth-positive
Aviv Clinics Highlights New Study Showing Hyperbaric Oxygen Therapy Can Improve Symptoms and Brain Structure of Veterans Suffering from Treatment-Resistant PTSD
Aviv Clinics, a leader in the research and treatment of age-related cognitive and functional decline, has shared the results of a study showing that hyperbaric oxygen therapy (HBOT) can improve symptoms and brain structure in veterans with treatment-resistant PTSD. The study was conducted by the Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center and Tel Aviv University. The clinical trial included 35 veterans who failed all current available treatments. The study revealed that HBOT treatment improved all PTSD symptoms, including intrusive symptoms, avoidance, cognition and mood changes, and depression. The findings suggest that HBOT-induced neuroplasticity could be a new therapeutic strategy for chronic PTSD. Aviv Clinics offers an advanced treatment program that includes HBOT, cognitive training, and personalized plans to improve patients quality of life.
Customers
growth-positive
Aging process data co Aviv Scientific raises $40m
Aviv Scientific, an Israeli cognitive and functional decline treatment company, has closed a $40 million oversubscribed Series B financing round led by Danel and Deep Insight Fund. The funding will be used to expand Avivs clinics globally, develop the Aviv Aging Database, and accelerate medical research. Aviv is focused on developing comprehensive OMICS data to understand the aging process in healthy adults and extend health-span. The company collects neuro-cognitive, physiologic, biomarkers, and genetic evaluations using comprehensive assessments and continuous monitoring. Avivs program combines Hyperbaric Oxygen Therapy with cognitive and physical training. The funding round reflects the companys clinical outcomes, team, partnerships, and technology. Aviv aims to be a leader in the healthy aging movement.
InvestmentExpand
growth-positive
https://www.jpost.com/must/must-innovate-664870
Aviv Scientific, an Israeli company specializing in research and treatment in the aging process, is establishing a medical center in Dubai. This collaboration symbolizes a new era of cooperation between the United Arab Emirates and Israel in advanced medicine. The center will focus on treating and optimizing brain and body performance and will be the second Aviv Clinic in the world. The opening of the center is one of the first examples of the implementation of the Abraham Accords and the normalization of relations between the countries. The center is expected to employ 100 staff members and will have a multidisciplinary team of medical professionals. The Aviv Clinics program, developed by Prof. Shai Efrati and the Aviv team, has been proven to improve cognitive abilities and reverse biological processes associated with aging.
Partners
growth-positive
Hyperbaric Oxygen Therapy extends life, the telomeres, and everything
Israeli company Aviv Scientific, co-owned by Dr Shai Efrati, has developed a Hyperbaric Oxygen Therapy (HBOT) treatment that can reportedly stop the aging of blood cells and reverse the aging process. The treatment involves high-pressure oxygen in a pressure chamber and has been found to reverse two major processes associated with aging: the shortening of telomeres and the accumulation of old and malfunctioning cells in the body. The companys business model is to offer HBOT to wealthy older individuals in Florida and Dubai.
CustomersInvestment
growth-positive
First-Time Human Study Shows Reversal in Biology of Aging - Telomere Shortening and Senescent Cells Accumulation - with Hyperbaric Oxygen Therapy (HBOT)
Tel Aviv University and The Sagol Center for Hyperbaric Medicine and Research have announced a new study that shows two key biological hallmarks of aging, telomere length shortening and accumulation of senescent cells, can be reversed in humans using hyperbaric oxygen therapy (HBOT). The study, part of a comprehensive research program targeting aging as a reversible disease, found that telomere length was significantly increased and senescent cells were reduced in a population of healthy aging subjects. This discovery has significant implications for the treatment and prevention of age-related diseases. The study was conducted on 35 healthy independent adults aged 64 and older, who received 60 daily HBOT sessions over 90 days. The results showed a significant increase in telomere length and a decrease in senescent cells.
Customers
growth-positive
Israeli doctor claims to 'reverse' aging with pure oxygen treatment study
An Israeli doctor claims to have found a way to reverse aging in the brain using oxygen therapy. Shai Efrati conducted a study with volunteers aged 65 and older, who experienced improved cognitive function and brain tissue function after receiving a 60-day course of treatment in a hyperbaric chamber. The results of the study were published in the journal Aging. Efrati co-founded Aviv Scientific, a company that has been developing oxygen therapy programs for healthy adults since 2017. The company plans to open a clinic in Dubai by the end of the year.
Customers
Aviv Scientific Team
Amir Hadanny
Chief Research & Head of International Clinical Operations
Employee Info
| Employees (range) | 11-50 |
| Exact count | 23 |
| Team members | 12 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 15 classification IDs that could be used for matching.
Aviv Scientific Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 93/100 |
| Missing | markets, not claimed |
| BI Verification | Yotam Maman |
| Registrar ID | 515687432 |
| Crunchbase | aviv-scientific |
| Creator | Yotam Maman |
| Creator email | yotamm1988@gmail.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2023-04-12T00:00:00.000Z |
| Created | 2021-09-30T00:00:00.000Z |
| Claimed | Yes |